Medical marijuana shown at AIDS meet.An exhibit on the therapeutic use of marijuana marijuana or marihuana, drug obtained from the flowering tops, stems, and leaves of the hemp plant, Cannabis sativa (see hemp) or C. indica; the latter species can withstand colder climates. (cannabis cannabis: see hemp; marijuana. cannabis Any plant of the genus Cannabis, which contains a single species, C. sativa. It is widely cultivated throughout the northern temperate zone. ) appeared at the XVI International AIDS Conference Education, networking and the promotion of best practice are essential to enhancing the response to HIV/AIDS. IAS conferences provide opportunities to share experience, and increase the knowledge and expertise of professionals working in HIV/AIDS. in Toronto. This was the first time that a display on the medical uses of marijuana has been presented at an AIDS conference. The exhibit points out the role of Canada's Marijuana Medical Access Regulations that enable Canadians to obtain drugs containing marijuana products, if needed and prescribed by a physician. The exhibit was co-hosted by the Canadian AIDS Society and the Medical Marijuana Information Resource Centre. The MMIRC is sponsored by Cannasat Therapeutics Inc., a company that researches and develops pharmaceutical products that target the endocannabinoid system The endocannabinoid system (ECS) tightly regulates the probability of neurotransmitter release in a host of neuronal tissues like the hippocampus, amygdala, basal ganglia, and cerebellum [1] [2] [3] Data from immunologists, developmental biologists, . www.cdnaids.ca |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion